Article Details
Retrieved on: 2022-07-02 09:09:56
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Renaissance Technologies LLC owned about 2.99% of Sonnet BioTherapeutics worth $677,000 at the end of the most recent reporting period. 12.26% of the ...
Article found on: www.etfdailynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here